AcuCort AB

Quotes

Through this choice of new partner AcuCort ensures a high quality, experienced and cost-effective performer of the bioequivalence studies who can help us with one of the most important steps towards market approval, according to the schedule that we have communicated.

Mats Lindfors, CEO of AcuCort

Dexa ODF is now another step closer to a registration application.

Mats Lindfors, CEO of AcuCort AB

Pick a time period -

Tags ( Active)

All Regulatory Non-Regulatory

AcuCort strengthens its organization and appoints interim CEO

Thu, Dec 12, 2019 10:36 CET

AcuCort AB (Spotlight Stock Market: ACUC) today announces that the company strengthens its organization and hires Ann Gidner as interim CEO. The current CEO Mats Lindfors will continue to work for AcuCort in a consulting role. The change will take effect on January 1, 2020.The current CEO Mats Lindfors has to the board expressed his wishes to scale down his involvement in AcuCort due to family reasons. The now announced change means that Ann Gidner takes over as interim CEO of AcuCort on January 1, 2020. At the same time, Mats Lindfors takes up a consulting role as support during a

There are no items matching the current filter

There are no more items matching the current filter

Back to top

Share

Quotes

AcuCort strengthens its organization and appoints interim CEO

Subscribe